pembrolizumab
merck,palleon pharma
['glimmer-01']
this week we ll be at 's annual meeting in boston presenting a trial in progress poster on glimmer-01, our ongoing phase 1/2 clinical trial of e-602 bi-sialidase for the treatment of multiple #cancer types. more on our presentation: #sitc22 